Updates from the Exchange

While the United States government (USG) continues to be the world’s largest funder of product development for global health, its funding...

Tedros Adhanom Ghebreyesus, PhD, has been elected Director-General of the World Health Organization (WHO)...

Several of the world’s major medical research funders and developers have agreed on new standards requiring public registration of any...

The International Partnership for Microbicides (IPM) has announced the start of a Phase I clinical trial of a vaginal ring to prevent HIV...

The injectable conntraceptive Sayana® Press, will be made available to qualified purchasers at a guaranteed public sector price of $0.85...

EVATAR is a microenvironment that mimics how organs in the female reproductive tract interact. Scientific progress on this microfluidic...

The World Health Organization (WHO) recently issued revised guidance on the use of the injectable contraceptives DMPA and NET-EN...

Researchers at Georgetown University’s Institute for Reproductive Health have launched a year-long study to measure the efficacy of Dot...

Mithra Pharmaceuticals announced its intention tosubmit Myring, a combined hormonal contraceptive vaginal ring, for marketing approval...

Targeting the earliest phase of product development, the Bill & Melinda Gates Foundation recently announced its Grand Challenge....

New data are available in the search for a new male contraceptive method. Safety, efficacy, and acceptability data from a phase II study...

Despite significant health innovations in the past 50 years, millions of people continue to be unable to access to these life-protecting....